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Abstract
Chondrocytes are the key target cells of the cartilage degeneration that occurs in Kashin–Beck disease (KBD) and
osteoarthritis (OA). However, the heterogeneity of articular cartilage cell types present in KBD and OA patients and
healthy controls is still unknown, which has prevented the study of the pathophysiology of the mechanisms
underlying the roles of different populations of chondrocytes in the processes leading to KBD and OA. Here, we aimed
to identify the transcriptional programmes and all major cell populations in patients with KBD, patients with OA and
healthy controls to identify the markers that discriminate among chondrocytes in these three groups. Single-cell RNA
sequencing was performed to identify chondrocyte populations and their gene signatures in KBD, OA and healthy
cells to investigate their differences as related to the pathogenetic mechanisms of these two osteochondral diseases.
We performed immunohistochemistry and quantitative reverse-transcription PCR (qRT-PCR) assays to validate the
markers for chondrocyte population. Ten clusters were labelled by cell type according to the expression of previously
described markers, and one novel population was identified according to the expression of a new set of markers. The
homeostatic and mitochondrial chondrocyte populations, which were identified by the expression of the unknown
markers MT1X and MT2A and MT-ND1 and MT-ATP6, were markedly expanded in KBD. The regulatory chondrocyte
population, identified by the expression of CHI3L1, was markedly expanded in OA. Our study allows us to better
understand the heterogeneity of chondrocytes in KBD and OA and provides new evidence of differences in the
pathogenetic mechanisms between these two diseases.
Introduction
Kashin–Beck disease (KBD), an endemic and chronic
degenerative osteochondral disease with irreversible
pathological and clinical signs, is characterised with
clinical manifestations including shortened and enlarged
fingers at early stage of onset of KBD, and deformed limb
joints, limited movement and even dwarfism in some
patients with advanced disease1,2. Osteoarthritis (OA) is
the most common chronic disease, involving progressive
joint dysfunction with ageing. Several similar pathological
changes have been found in KBD and OA, including
extracellular matrix (ECM) degradation, cartilage lesions,
and reduction and disruption of proteoglycans (PGs) and
collagens3–6. However, the age of onset, symptoms and X-
ray findings differ between KBD and OA3, which suggests
that they are caused by different aetiologies and have
distinct pathogeneses. Meanwhile, adult KBD patients
typically have advanced KBD, often accompanied by
OA4,6. Recent studies have found differences in various
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cellular pathways between KBD and OA chondrocytes5,7,8,
suggesting differences in multiple processes, such as
metabolism, apoptosis, adaptive immune defence, cytos-
keleton, cell movement and extracellular matrix turn-
over4,9–12. However, these studies do not take into
consideration the heterogeneity of articular cartilage cell
types and therefore may be missing important informa-
tion on cartilage degeneration processes specific to
KBD or OA.
Articular cartilage is a highly organised structure com-
posed of multiple zones, namely, the superficial, middle,
deep and calcified zones, which display three chondrocyte
phenotypes: persistent, transient and hypertrophic
cells13,14. The chondrocyte phenotype, cell shape, and
extracellular matrix (ECM) structure are different among
the different zones13–15. In a previous study, seven defined
populations of chondrocytes were identified in OA carti-
lage, specifically, proliferative chondrocytes (ProCs), pre-
hypertrophic chondrocytes (PreHTCs), hypertrophic
chondrocytes (HTCs), fibrocartilage chondrocytes (FCs)
and three novel populations with distinct functions16. In
addition, senescent cells (SNCs) and cartilage progenitor
cells (CPCs) were also identified in recent studies17–20.
Specific chondrocyte populations may play important
roles in osteochondral diseases such as KBD and OA. For
example, PreHTCs are capable of regulating the onset of
hypertrophic differentiation, while HTCs can modulate
the mineralisation of the surrounding matrix in the car-
tilage16, processes that are known to be more active in OA
cartilage21,22. Additionally, CPCs have the ability to self-
renew and differentiate along multiple lineages, thereby
contributing to cartilage repair and homeostasis, and their
dysregulation may affect and modulate cartilage loss in
the processes of OA and KBD17,20.
One of the main differences in pathological changes
between KBD and OA is in the location of the primary
cartilage loss. OA is characterised primarily by progressive
degradation starting in the superficial zone, with sub-
sequent inflammation. In contrast, the primary char-
acteristic pathological changes of KBD patients were
chondrocyte necrosis occurring in the deep zone of
articular cartilage and hypertrophic layers of epiphyseal
plate cartilage23,24. However, the pathological changes in
the different chondrocyte populations in KBD cartilage
have not yet been studied, and we therefore do not yet
have a full understanding of the difference in cartilage
degeneration mechanisms between OA and KBD.
Single-cell RNA sequencing (scRNA-seq), a novel and
powerful method for investigating transcriptomic cell-to-
cell variation, is widely applied to identify various cell
types and provide insights into the pathological processes
of diseases25–28. In this study, scRNA-seq was used to
better understand the changes occurring in the chon-
drocytes from patients with KBD and OA. The results
allowed us to better understand the heterogeneity of
chondrocytes between KBD and OA and provided us with
new evidence to explore the differences in the pathoge-
netic mechanisms between these two diseases.
Results
scRNA-seq census of healthy human chondrocytes
identified seven distinct cell populations
To determine the cellular composition of chondrocytes,
we profiled chondrocytes from healthy human cartilage
tissues using scRNA-seq. Unbiased clustering of the
chondrocytes resulted in seven clusters originating from
healthy human cartilage tissues (Fig. 1A). Specifically, the
following cells were identified: fibrocartilage
chondrocytes-1 (FCs-1, expressing SH3BGRL3, S100A6
and MYL9), fibrocartilage chondrocytes-2 (FCs-2,
expressing IGFBP5 and LMCD1), cartilage progenitor
cells-1 (CPCs-1, expressing CDC20, UBE2C, CENPF and
CKAP2), regulatory chondrocytes (RegCs, expressing
EIF5A, PGK1, ANXA1 and TUBA1A), prehypertrophic
chondrocytes (preHTCs, expressing SOX9, COL9A3 and
COL11A1), homeostatic chondrocytes (HomCs, expres-
sing TXNIP, IFITM3, GDF15 and TIMP1) and cartilage
progenitor cells 2 (CPCs-2, expressing KIAA0101, BIRC5,
CDKN3 and TMMN1) (Fig. 1C, D).
Single-cell trajectory of normal chondrocyte differentiation
To study the differentiation of healthy human chon-
drocytes into different clusters and the corresponding
gene expression, we used monocle to reconstruct the
pseudotime trajectory (Fig. 1B). We found that the root of
the trajectory was mainly populated by CPCs-1 and CPCs-
2, while FC-1 was distributed in the middle of the tra-
jectory, FC-2 was distributed along the trajectory, RegCs
were located in front of FCs, and PreHTCs were behind
FCs. PreHTCs and HTCs were mainly distributed at the
end of the trajectory. The two termini of the tree were
populated by FC-1 and RegCs for fate 1 and FC-2,
PreHTCs and HomCs for fate 2 (Fig. 1B).
Next, we assessed the expression of genes whose levels
varied during CPC differentiation in cells at fates 1 and 2
of the trajectory. The expression of COL1A1, IGFBP6,
CALR, SULF1, ACTB, LGALS1 and PFN1 was found to
be similar in both groups. COL1A1, IGFBP6, CALR and
SULF1 expression was slightly reduced, while ACTB,
LGALS1 and PFN1 expression was slightly increased, at
the early stage of differentiation, notably downregulated
in fate 2 cells and upregulated in fate 1 cells. FMOD,
DDIT4, IGFBP5, BGN, ZFAS1, FTL, COMP and CHI3L1
were slightly downregulated at the early stage of differ-
entiation, notably upregulated in fate 2 and down-
regulated in fate 1. In contrast, CEMIP, ACTA2, PTX3,
TAGLN, CCL2, ADAMTS1 and SERPINE1 expression
decreased slightly in cells from the root to fate 2 but
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Fig. 1 Single-cell RNA-sequencing analysis of human healthy control chondrocyte tissue samples. A Seven healthy human chondrocyte
clusters. Visualisation of clustering by t-SNE plot of healthy control samples, identified by cell type. B Monocle pseudotime trajectory showing the
progression of seven clusters of healthy chondrocytes. C Heat map of scaled gene expression data for the top 10 differentially expressed genes identifying
each cluster, with selected genes listed. D Gene expression plots demonstrating high expression of SH3BGRL3 in SH3BGRL3hi fibrocartilage chondrocytes-
1, IGFBP5 in IGFBP5hi fibrocartilage chondrocytes-2, CDC20 in CDC20hi cartilage progenitor cells-1, KIAA0101 in KIAA0101hi cartilage progenitor cells-2,
EIF5A in EIF5Ahi regulatory chondrocytes, SOX9 in SOX9hi prehypertrophic chondrocytes and TXNIP in TXNIPhi homeostatic chondrocytes. Dot colour
corresponds to the level of gene expression in each cell. t-SNE, t-distributed stochastic neighbour embedding. E Representative immunohistochemistry
staining of SH3BGRL3, IGFBP5, BIRC5, SOX9, EIF5A and CDC20 in healthy cartilage tissues. Scale bar, left, 500 μm; right, 50 μm, and quantification of positive
cells of different areas (superficial, middle, deep) in cartilage tissues displayed by box plot (n= 5). *p < 0.05.
Wang et al. Cell Death and Disease          (2021) 12:551 Page 3 of 15
Official journal of the Cell Death Differentiation Association
markedly increased in cells that differentiated via fate 1
(Supplementary Fig. 1).
To study the distribution of different cell clusters, we
used immunohistochemistry to detect marker gene
expression (Fig. 1E). The results revealed that FCs were
mainly distributed in the superficial and middle zones,
CPCs were mainly distributed in the middle and deep
zones, RegCs were mainly distributed in the superficial
zone, and PreHTCs were mainly distributed in the
superficial and deep zones.
Systemic comparison of the single-cell landscape among
KBD, OA and healthy human chondrocytes
We compared scRNA-seq among healthy chondrocytes,
KBD chondrocytes and OA chondrocytes. In total, 16,375
cells were analysed, with 6140 cells from patients with
KBD, 5834 cells from patients with OA and 4401 cells
from healthy controls. Ten clusters were labelled by cell
type using the expression of previously described markers,
and one novel population, mitochondrial chondrocytes
(MTCs), was identified by the expression of novel markers
(Fig. 2A). PreHTCs, identified as positive for S100A4,
COL9A3 and AKR1C1, were divided into three primary
subgroups of 6 clusters: the first expressing S100A4,
TAGLN and SH3BGRL3 (S100A4hi), the second expres-
sing COL9A3, SOX9 and COL11A1 (COL9A3hi) and the
third expressing AKR1C1, LUM and AKR1C2
(AKR1C1hi). RegCs were found in six separate clusters,
which were divided into two primary subgroups: the first
expressing CTNNB1, TUBA1A and CDC42 (CTNNB1hi)
and the second expressing CHI3L1, AEBP1 and STEAP1
(CHI3L1hi). MTCs, the novel population in this study,
were found in two separate clusters, the first expressing
MT-ND1, MT-ATP6 and MT-ND2 (MT-ND1hi) and the
second expressing MT-CO1, MT-CO3 and MT-CYB
(MT-CO1hi). FCs were found in seven separate clusters,
which were divided into two primary subgroups: the first
expressing IGFBP5, TPM1 and ADAMTS1 (IGFBP5hi)
and the second expressing COL14A1, NOTCH3
and COL6A3 (COL14A1hi) (Fig. 2B, C and Supplementary
Fig. 2).
When separating t-SNE plots for each disease state, we
noted that cluster 8, representing CPC cells, was present
only in normal cartilage and was largely missing in both
OA and KBD samples (Fig. 2D). In addition, an analysis of
the proportion of total cells present in each population by
sample and disease status revealed several significant
changes among normal chondrocytes, KBD chondrocytes
and OA chondrocytes (Fig. 2E). The populations of RegCs
and prehypertrophic chondrocytes increased in OA
chondrocytes compared with healthy control and KBD
chondrocytes. Meanwhile, the numbers of hypertrophic
chondrocytes, FCs and MTCs tended to increase from
controls and OA to KBD.
Expanded cell population cluster in KBD samples
Two distinct chondrocyte populations seem to be
expanded mainly in KBD samples compared to normal
and OA samples. These include the novel MTCs and
HomCs (Fig. 2D). HomCs were identified by their
expression of the known markers MT1X, MT2A, MT1E,
ATF5 and DDIT3. Another distinct population that was
markedly expanded in KBD was the MTCs, which is a
newly defined population that is identified by a signature
that includes genes related to mitochondrial electron
transport and the response to hydroperoxide, including
the MT-ND1, MT-ATP6, MT-ND2 and MT-ND3 genes.
The expression of MT-ND1 and MT1X in cartilage tis-
sues was investigated by using immunohistochemistry
assays, which validated the existence of MTCs and
HomCs in KBD cartilage. The results showed that MTCs
were mainly distributed in the middle and deep zones, and
HomCs were mainly distributed in the superficial zone in
KBD cartilage (Fig. 2F). Moreover, we validated the gene
expression of MT-ND1 and MT1X in patients with KBD
using RT-PCR and found that the results were consistent
with the single-cell RNA-seq analysis (Supplementary
Fig. 3).
Expanded cell population cluster in OA and normal
samples
A distinct regulatory chondrocyte population that was
markedly expanded in OA (Fig. 2D) was identified by its
expression of the known markers CHI3L1, AEBP1, PLIN2
and STEAP1 (Fig. 3A). The expression of AEBP1, CHI3L1
and STEAP1 in cartilage tissues was investigated by using
immunohistochemistry assays and validated the existence
of RegCs in OA cartilage. The results showed that AEBP1
was upregulated in the superficial and middle zones, and
CHI3L1 and STEAP1 were upregulated in the superficial,
middle and deep zones of OA cartilage tissues compared
to normal cartilage tissues (Fig. 3B). In addition, we
validated the gene expression of AEBP1 and CHI3L1 in
patients with OA using RT-PCR and found that the
results were consistent with the single-cell RNA-seq
analysis (Supplementary Fig. 3).
Distinct CPCs, which were markedly expanded in nor-
mal tissue (Fig. 2D), were identified by their expression of
the known markers STMN1, PTTG1, CDKN3, BIRC5,
UBE2S and CENPW (Fig. 4A). Although none of these
markers were exclusive to CPCs, this cluster was the only
population expressing all of these genes. We investigated
the expression of CENPW and PTTG1 in cartilage tissues
by using immunohistochemistry assays and validated the
existence of CPCs in normal cartilage (Fig. 4B). The
results revealed that CENPW was upregulated in the
middle zone and PTTG1 was upregulated in the middle
and deep zones in cartilage tissues from normal controls.
In addition, the expression of PTTG1 and BIRC5 was
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investigated in cartilage tissues from OA and KBD
patients, and the results showed that PPTG1 and BIRC5
were upregulated in the superficial zone of OA cartilage,
while they were upregulated in the deep zone of KBD
cartilage (Supplementary Fig. 4).
Alignment of single-cell trajectory in normal, KBD and OA
chondrocytes
To further investigate the relationship between the
different disease statuses, we used monocle to study the
transitions across specific cell types and sample states. We
found that the pseudospace trajectory axis derived from
monocle yielded three different trajectory states (Fig. 4C).
Chondrocytes from normal cartilage were present at the
start of the pseudospace trajectory, which then branched
into 2 distinct fates, populated mainly with either KBD
(fate 1) or OA (mostly fate 2) (Fig. 4D).
Next, we assessed the expression of genes regulated
during chondrocyte differentiation in cells at fates 1 and 2
of the trajectory. The expression levels of FN1, CHI3L2,
RGCC, COL9A3 and MDFI were markedly upregulated in
cells at fate 1, whereas those of COL11A1, SMOC2 and
FBXO2 were slightly downregulated at the early stage of
differentiation and notably upregulated in cells at fate 1.
HMOX1, COL1A1, WISP2, CD9 and PCOLCE were
notably upregulated in cells at fate 2 and downregulated
in cells at fate 1. IGF1, VCAN, PCSK5 and SPP1 were
upregulated only in cells at fate 2 (Fig. 4E). These genes
were differentially expressed at the prebranch point,
suggesting that these genes may play a critical role in
regulating the phenotype of chondrocytes at the begin-
ning of the process of differentiation or development of
chondrocytes from healthy controls to KBD or OA.
Prehypertrophic chondrocytes, hypertrophic
chondrocytes, regulatory chondrocytes and effector
chondrocytes
Prehypertrophic chondrocytes, hypertrophic chon-
drocytes, RegCs and effector chondrocytes from clusters 3
and 4 (Fig. 5A, B) were combined and reclustered to
allow clearer identification of these subpopulations.
Hypertrophic chondrocytes-A (HTC-A) and hypertrophic
chondrocytes-B (HTC-B) were marked by the robust
expression of IGF2 and SLC5A3, MMP3 and GDF5.
PreHTCs and ECs highly expressed S100A4 and HLA-B,
MIA and PLA2G2A, respectively. CHI3L1 and AEBP1
were highly expressed in RegCs (Fig. 5C).
Fibrocartilage chondrocyte subpopulation
Upon examining FC populations in the combined ana-
lysis of KBD, OA and healthy human chondrocytes, we
again identified distinct populations of IGFBP5hi and
COL14A1hi FCs, each containing KBD, OA and healthy
human chondrocytes. Two major and three minor sub-
populations of FCs emerged (Fig. 6A, B). The first major
population was defined by the expression of RPS4Y1 and
PENK (RPS4Y1hi FCs). A second major population was
defined by the expression of COL3A1 (COL3A1hi FCs).
Three minor populations were distinguished by the
expression of FGF1, IGFBP6 and COL14A1 (Fig. 6C).
Identification of effector and hypertrophic chondrocyte
populations in KBD and OA chondrocytes
We separately analysed chondrocytes from patients with
KBD and OA. Seven populations of chondrocytes were
identified in both KBD and OA. The EC population was
defined by the expression of MIA, S100B, FRZB, C2orf82
and S100A1 in both KBD and OA (Supplementary Fig. 5),
suggesting that these markers from ECs were char-
acterised as having the same expression pattern in KBD
and OA. In addition, HTCs were defined by the expres-
sion of IBSP, MMP13, RUNX2 and TMEM119 in KBD
chondrocytes (Supplementary Fig. 6).
Discussion
The pathogenesis of KBD and OA is different in many
aspects. KBD mainly invades the epiphyseal cartilage,
epiphyseal plate cartilage and articular cartilage and
occurs in children aged 3–12 years. This progressive
lesion seriously affects the growth and development of
children’s bones. Unlike KBD, OA is a degenerative
chronic joint disease that mainly occurs in elderly
(see figure on previous page)
Fig. 2 Single-cell RNA-sequencing analysis of human healthy control, KBD chondrocyte and OA chondrocyte tissue samples. A Visualisation
of clustering by t-SNE plot of all combined healthy control, KBD and OA samples, identified by cell type. B T-SNE plots demonstrating the gene
expression of previously described markers used to identify the cell identity of each cluster: S110A4-prehypertrophic chondrocytes; CTNNB1-
regulatory chondrocytes type 1; MMP13- hypertrophic chondrocytes; FRZB- effector chondrocytes; CHI3L1-regulatory chondrocytes type 2; NGF-
proliferative chondrocytes; MT1X-homeostatic chondrocytes; OLFM2-fibrocartilage chondrocytes; STMN1-cartilage progenitor cells. Dot colour
corresponds to the gene expression level in each cell. t-SNE, t-distributed stochastic neighbour embedding. C Heat map of scaled gene expression
data for the top 5 differentially expressed genes identifying each cluster, with selected genes listed. t-SNE, t-distributed stochastic neighbour
embedding. D t-SNE plot of cells according to disease status; different clusters contained different numbers of cells from KBD, OA and control
samples. E Mean percentage of total cells that comprised each cell type, comparing control, KBD and OA samples. Bars indicate the percentage of
total cells. F Representative immunohistochemistry staining of MT-ND1 and MT1X in KBD cartilage tissues. Scale bar, left, 500 μm; right, 50 μm, and
quantification of positive cells of different areas (superficial, middle, deep) in cartilage tissues displayed by box plot (n= 5). *p < 0.05.
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individuals. Currently, we cannot distinguish KBD and
OA well at the molecular level or propose precise treat-
ment strategies for the two diseases. There are limited
specific cell markers to report the internal status of
chondrocytes in KBD and OA pathogenesis. Therefore, in
this study, we performed a comprehensive analysis of
Fig. 3 Single-cell RNA-sequencing analysis of the cell population in OA. A Gene expression plots of CHI3L1, AEBP1, STEAP1 and PLIN2. Dot
colour corresponds to the level of gene expression in each cell. t-SNE, t-distributed stochastic neighbour embedding. B Representative
immunohistochemistry staining of AEBP1, CHI3L1 and STEAP1 in OA and healthy cartilage tissues. Scale bar, left, 500 μm; right, 50 μm, and
comparative quantification of positive cells of different areas (superficial, middle, deep) between OA and healthy cartilage tissues displayed by box
plot (n= 5). *p < 0.05.
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Fig. 4 Single-cell RNA-sequencing analysis of the cell population in healthy controls. A Gene expression plots of CENPW, PTTG1 and BIRC5. Dot
colour corresponds to the level of gene expression in each cell. t-SNE, t-distributed stochastic neighbour embedding. B Representative
immunohistochemistry staining of CENPW and PTTG1 in healthy cartilage tissues. Scale bar, left, 500 μm; right, 50 μm, and quantification of positive
cells of different areas (up, middle, deep) in healthy cartilage tissues displayed by box plot (n= 5). *p < 0.05. C, D Monocle pseudotime trajectory
showing the progression of KBD, OA and the control. E The expression of the genes in a branch-dependent manner. Each row indicates the
standardised kinetic curves of a gene. The centre of the heatmap shows the kinetic curve value at the root of the trajectory. From the centre to the
left of the heatmap, the kinetic curve progresses from the root along the trajectory to fate 1. Starting from the right, the curve from the root to fate 2.
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chondrocyte populations in KBD, OA and healthy control
cartilage. We identified a new population of chondrocytes,
MTCs, and, identified the relationships among KBD, OA
and healthy control chondrocytes at the cellular level. The
HomC and MTC populations were markedly expanded in
KBD. The RegC population was markedly expanded in
OA, and CPCs were markedly expanded in healthy con-
trols. Our results thus identified the major cell popula-
tions in patients with KBD, OA and healthy controls and
the corresponding marker genes, which provide a novel
foundation for further exploration of the differences in the
pathogenetic mechanisms involved in KBD and OA.
Currently, mitochondrial studies are involved in bio-
medicine due to their critical roles in ageing and disease
development in humans29. Mitochondria are organelles
that can generate most of the energy essential to the cell
by converting nutritional molecules into adenosine tri-
phosphate (ATP). An increase the production of reactive
oxygen species (ROS) and a decrease in the consumption of
ATP and oxygen by a series of metabolic alterations can be
caused by mitochondrial dysfunction. Mitochondrial dys-
function also leads to an inflammatory response, which
induces the synthesis of cytokines and matrix metallopro-
teinases (MMPs)30. Compared with that in normal cartilage,
mitochondrial biogenesis in KBD and OA chondrocytes is
altered, such that there is a reduction in the activities of
complexes II, III, IV and V31,32, which causes failure in
energy generation. Hence, mitochondrial function needs
correction to prevent excessive production of ROS and
oxidative stress30. In this study, we identified a new popu-
lation of MTCs that are markedly expanded in KBD and
express genes related to ATP synthase in chondrocytes, the
inflammatory response, calcium metabolism and chon-
drocyte survival32. These observations suggest that MTCs
are active in energy supply. In a previous study, signs of
mitochondrial dysfunction were identified in cultured KBD
Fig. 5 Recluster analysis of prehypertrophic chondrocytes, hypertrophic chondrocytes, regulatory chondrocytes and effector
chondrocytes. A Visualisation of reclustering by t-SNE plot of the original cluster 3 and 4, identified by cell type. B T-SNE plots demonstrating the
gene expression of markers used to identify the cell identity of each cluster. Dot colour corresponds to the level of gene expression in each cell. C
Violin plots of gene expression of chondrocyte markers by reclustering original clusters 3 and 4.
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chondrocytes, including decreased cellular ATP levels, an
increased ratio of cells with de-energised mitochondria,
release of mitochondrial cytochrome c and elevated activa-
tion of caspases 9 and 3. In addition, the number of
apoptosis-positive chondrocytes in patients with KBD was
larger than that in healthy controls24,31. All these findings
suggest that mitochondrial dysfunction and mitochondria-
mediated cell death play critical roles in the pathophysiology
of KBD.
We also identified a second novel cell population,
HomCs. These cells were mainly present among KBD
chondrocytes and exhibited high expression levels of
metallothionein (MT) genes. MTs play diverse roles in
metal detoxification, antioxidant functions, immune
defence and cell differentiation. MTs are also important in
regulating intracellular ROS levels33,34. A previous study
also indicated that oxidative stress is the common
pathological change in juvenile KBD patients recruited
from both severely affected and mildly affected endemic
regions. Severe oxidative stress is also associated with the
occurrence and development of KBD35. The evidence
above suggests that these HomCs might play a protective
role against apoptosis by scavenging ROS and controlling
cellular oxidative stress in KBD.
Although lacking intrinsic reparative ability, articular
cartilage contains a population of cells with progenitor-
Fig. 6 Recluster analysis of fibrocartilage chondrocytes. A Visualisation of reclustering by t-SNE plot of the original clusters 3 and 4, identified by
cell type. B T-SNE plots demonstrating gene expression of markers used to identify the cell identity of each cluster. Dot colour corresponds to the
level of gene expression in each cell. C Violin plots of gene expression of chondrocyte markers by reclustering original fibrocartilage chondrocytes.
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like qualities36–41 that are similar to stem cells.42. This
population of chondrocytes is known as CPCs and has
been observed and isolated in human articular cartilage
and characterised by their capacity for self-renewal,
expression of stem cell-related surface markers and ability
to differentiate along multiple lineages17. Since Dow-
thwaite et al.43 first reported the isolation of CPCs from
the surface zone of articular cartilage, CPCs have been
detected mostly in the superficial zone of articular carti-
lage in a number of studies44,45. CPCs have also been
found to participate in cartilage self-repair during early or
later stages of human OA20,46,47 and were found to be
highly migratory towards damaged cartilage tissue and
repopulated in repair tissue. However, another study
indicated that PRG4-expressing cells served as a pro-
genitor population of cartilage and were mainly found in
superficial chondrocytes in young mice but expanded into
deeper regions of articular cartilage as animals aged48. Yu
et al.49 demonstrated that CPCs can be isolated from both
the superficial and deep bovine articular cartilage and
identified CPCs in healthy articular cartilage by a single-
cell clonogenicity screening technique for the first time. In
our study, the CPC population was mainly found in the
middle and deep zones of normal healthy cartilage and
possessed a high proportion of genes related to self-
renewal ability, differentiation multipotency and migra-
tion20,50. The expression of CPC markers (PTTG1 and
BIRC5) in OA and KBD cartilage tissues showed that
CPCs were distributed in the superficial zone in OA
cartilage and in the deep zone in KBD cartilage. These
inconsistent results for the expression of CPC markers in
OA and KBD may be caused by their different injury
patterns to cartilage; OA is characterised by progressive
degradation on the cartilage surface, while the degen-
erative changes in KBD cartilage are characterised by
multiple foci of chondronecroses in the deep zone of the
cartilage24. On the basis of these data, we inferred that the
CPCs from the superficial zone in OA might actually
originate or migrate from the middle and deep zones of
CPCs in healthy articular cartilage. Moreover, CPCs could
migrate extensively towards damaged cartilage tissue
parts and repopulate in repair tissue.
Because healthy controls and KBD patients now rarely
undergo surgical cartilage biopsy, our study was limited
by a relatively small sample size. Cartilage samples were
collected from only three pairs of patients and healthy
controls, which may lead to statistical bias caused by the
individual characteristics of the limited number of sub-
jects. In addition, there is no evidence of sex differences in
KBD, but a large number of studies have shown that
women have a higher prevalence of knee OA than men,
particularly after the age of 5051,52. In this study, to avoid
the statistical bias caused by sex differences, all three
cartilage samples used in scRNA-seq analysis were
collected from female donors; however, we cannot ignore
the influence of the sex bias of knee OA on the outcomes
of the scRNA-seq analysis in future analyses. Therefore,
we performed IHC to verify the results of scRNA-seq
analysis and confirm similar results in cartilage from both
women and men.
In conclusion, our study systemically compared the
single-cell landscapes of KBD, OA and healthy chon-
drocytes. This analysis identified discriminative markers
for specific chondrocyte populations, which may be con-
sidered targets for cartilage injury repair or key molecules
in the pathogeneses of these two diseases. A new popu-
lation, MTCs, was markedly expanded in KBD, and this
expansion may represent an important mechanism of
chondrocyte degeneration in KBD.
Materials and methods
Sample recruitment
The patients with KBD were diagnosed strictly accord-
ing to the national diagnostic criteria of KBD in China
[WS/T 207-2010]. The patients with OA were diagnosed
strictly according to the Modified Outerbridge Classifi-
cation. All subjects with alterations such as defects and
sclerosis on the bone end of phalanges combined with
compression changes of the calcaneus and talus and
enlarged/deformed limb joints (hand, elbow, knee, ankle,
etc.) manifested on X-ray were diagnosed with KBD.
Subjects were excluded if they were suffering or had
previously suffered from any other osteoarticular diseases
(such as rheumatoid arthritis, gout or skeletal fluorosis) or
any other type of macrosomia, disorder of osteochon-
drodysplasia or chronic disease (such as hypertension,
diabetes or coronary heart disease) or had received any
treatment in the past six months. Clinical information was
collected from patient records. Articular cartilage samples
from KBD and OA patients were collected from indivi-
duals who underwent arthroplasty of the knee. Healthy
controls were obtained from the patients who suffered
trauma or amputation due to an accident.
All donors signed a written informed consent form. All
subjects were of Chinese Han lineage. Adult articular
cartilage specimens were collected from one KBD patient,
one OA patient and one healthy subject (Table S1) for
single-cell RNA-seq and from five KBD patients, five OA
patients and five healthy subjects (Table S2) for immu-
nohistochemistry verification and from three KBD
patients, three OA patients and three healthy subjects
(Table S2) for qRT-PCR verification.
Cartilage tissue collection and chondrocyte isolation
All articular cartilage samples, including all of the car-
tilage zones (including calcified) and subchondral bone,
were harvested from the lateral tibial plateau and obtained
within 1 h after operation. Chondrocytes were isolated as
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follows:53–56 articular cartilage specimens were washed
twice with sterile phosphate-buffered saline (PBS) with
antibiotics (penicillin and streptomycin), cut into pieces
(1 mm3), and subjected to enzymatic digestion with 0.25%
trypsin at 37 °C in an atmosphere of 5% CO2 for up to
30min. Cell suspensions were centrifuged at 1000 × g for
5 min, the supernatant was aspirated completely, and the
cells were digested in basal media supplemented with
0.2% type II collagenase at 37 °C using an Eppendorf
Thermomixer for 12–16 h. Isolated chondrocytes were
filtered through 70mM nylon filters, washed twice with
sterile PBS and then directly prepared for cDNA ampli-
fication and scRNA-Seq library construction.
Single-cell RNA sequencing
Cell capture and cDNA synthesis
The Chromium Single Cell 3′ Library and Gel Bead Kit
V2 (10x Genomics, 120237) and Single Cell A Chip Kit
(10x Genomics, 120236) were used for cell capture. The
cell suspension (300–600 living cells per microlitre, as
determined by Count Star) was loaded onto the Chro-
mium Single Cell Controller (10x Genomics) to generate
single-cell gel beads in emulsion (GEMs) according to the
manufacturer’s protocol. In short, single cells were sus-
pended in PBS containing 0.04% BSA. Approximately
3173 cells were added to each channel, and the target cell
recovery was estimated to be ~16,544 cells in total. Cap-
tured cells were lysed, and the released RNA was bar-
coded through reverse transcription in individual GEMs.
Reverse transcription was performed on a S1000TM
Touch Thermal Cycler (Bio Rad) at 53 °C for 45min,
followed by 85 °C for 5 min and a hold at 4 °C. cDNA was
generated and then amplified, and quality was assessed
using an Agilent 4200 (performed by CapitalBio Tech-
nology, Beijing).
Single-cell RNA-Seq library preparation
According to the manufacturer’s instructions, single-
cell RNA-seq libraries were constructed using the Single
Cell 3′ Library Gel Bead Kit V2. The libraries were
sequenced using an Illumina NovaSeq6000 sequencer
with a sequencing depth of at least 57,374 reads per cell
with a paired-end 150 bp (PE150) reading strategy (per-
formed by CapitalBio Technology, Beijing).
Seurat pipeline
Clustering was also performed with Seurat 3.0 (R
package). Cells with a gene number was <200, a gene
number ranked in the top 1%, or a mitochondrial gene
ratio of >25% were regarded as abnormal and filtered out.
Dimensionality reduction was performed using principal
component analysis (PCA), and visualisation was realised
by TSNE and UMAP.
Enrichment analysis
GO enrichment, KEGG enrichment, Reactome enrich-
ment and disease enrichment (human only) of cluster
markers were performed using KOBAS software with
Benjamini–Hochberg multiple testing adjustment, using
the top 20 marker genes for each cluster. The results were
visualised in R.
Single-cell trajectory analysis
Single-cell trajectories were built with Monocle (R
package) for pseudotime analyses. Genes were filtered by
the following criteria: expressed in more than 10 cells;
average expression value >0.1; and Qval < 0.01 in different
analyses.
WGCNA
Weighted correlation network analysis (WGCNA) was
performed by the WGCNA R software package with
default parameters. According to the above clustering
results, every cluster was divided into subclusters, and the
average expression of genes in a subcluster was calculated.
Cell type annotation
Cell type annotation was carried out by SingleR (https://
bioconductor.org/packages/devel/bioc/html/SingleR.
html), which performs unbiased cell type recognition
from single-cell RNA sequencing data by leveraging
reference transcriptomic datasets of pure cell types to
infer the cell of origin of each single cell independently.
The human blueprint_encode and Human Primary Cell
Atlas (HPCA) reference datasets were used.
RNA extraction and quantitative reverse-transcription PCR
verification
Total RNA was isolated from chondrocytes using the
Trizol protocol. The RNA was then converted into
complementary DNA (cDNA) by RT-PCR using the
RevertAid™ First Strand cDNA Synthesis Kit (Thermo
Scientific Molecular Biology, Canada) according to the
manufacturer’s instructions. qRT-PCR was performed
using an ABI7500 Real-Time PCR system (Applied Bio-
systems, Foster City, CA, USA) according to the manu-
facturer’s instructions. All primer and probe sets were
supplied by TaqMan® Gene Expression Assays (Applied
Biosystems). The relative expression level of the gene was
calculated using the comparative Ct method. β-actin was
used as an internal control to normalise the sample
differences.
Immunohistochemical verification
Cartilage tissues were fixed with 4% (w/v) paraf-
ormaldehyde for 24 h immediately after acquisition and
decalcified in 10% (w/v) ethylenediaminetetraacetic acid
disodium salt (EDTA-Na2) for 2–3 weeks. The samples
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were dehydrated in an alcohol series, cleared in xylene
and embedded in paraffin wax. Paraffin sections were cut
into 5-µm sections, mounted on slides and stored at room
temperature until use for staining. The paraffin-
embedded sections were baked at 65 °C for 1 h, depar-
affinized with xylene and then rehydrated in decreasing
concentrations of ethanol. Endogenous peroxidase activity
was blocked by 0.3% (w/v) hydrogen peroxide for 10 min
at room temperature, and then the sections were washed
with 1×PBS. Then, the sections were incubated in 10mol/
L urea solution diluted with water at 37 °C for 20min and
washed with 1×PBS. For analysis of extracellular markers,
such as IGFBP5 and CHI3L1, the sections were treated
with 2 mg/ml hyaluronidase at pH 5.0 and 37 °C for
30min. For analysis of intracellular markers, the sections
were incubated in 0.1% trypsin/CaCl2 at 37 °C and
digested for another 20min for antigen retrieval. After
blocking with 5% (w/v) goat serum for 20min at room
temperature, anti-SH3BGRL3 (1:200 dilution, bs-21171R,
Bioss), anti-Survivin (1:100 dilution, bs-0615R, Bioss),
anti-IGFBP5 (1:100 dilution, bs-0406R, Bioss), anti-SOX9
(1:100 dilution, bs-4177R, Bioss), anti-EIF5A (1:100 dilu-
tion, DF6754, Affinity Biosciences), anti-CDC20 (1:50
dilution, 10252-1-AP, Proteintech), anti-MT-ND1 (1:50
dilution, 19703-1-AP, Proteintech), anti-MT1X (1:50
dilution, 17172-1-AP, Proteintech), anti-AEBP1 (1:100
dilution, bs-0322R, Bioss), anti-CHI3L1 (1:100 dilution,
bs-1093R, Bioss), anti-STEAP1 (1:100 dilution, bs-1901R,
Bioss), anti-CENPW (1:100 dilution, bs-15230R, Bioss) or
anti-PTTG1 (1:100 dilution, AF0354, Affinity Biosciences)
antibodies and IgG as a negative control were applied on
the sections, and the samples were further incubated
overnight at 4 °C. After washing with 1×PBS, sections
were incubated using a human serum amyloid P (SAP) kit
(solution B contains a goat anti-rabbit secondary anti-
body; Zhongshan, Jinqiao, Guangzhou, China) according
to the manufacturer’s instructions. The substrate 3,3′-
diaminobenzidine was added to stain the sections, and
haematoxylin counterstaining was performed. Finally, the
sections were dehydrated and mounted under alcohol-
cleaned coverslips. All IHC staining was assessed under
light microscopy by two pathologists who were blinded to
the origin of the samples. Each zone was identified based
on previously reported characteristics39,57–59 and articular
cartilage was divided into three cell morphologies,
namely, the superficial, middle and deep zones, according
to light microscopy observation. Chondrocytes in the
superficial zone were relatively small and flat and were
oriented with the long axis parallel to the surface; cells in
the middle zone were larger and more rounded and were
randomly distributed in the matrix with fibres running in
oblique directions; and cells in the deep zone were larger
in size and were arranged in a columnar manner per-
pendicular to the surface. Assessment of the staining
throughout each cartilage zone included systematic
counting of positive and negative cells, starting from the
cartilage surface and progressing down through all layers
of cartilage. Five randomly chosen fields in each zone
were counted at ×50 magnification. The percentage of
positive cells was calculated using the number of posi-
tively stained cells divided by the total number of cells
(positively and negatively stained cells) in the chosen
fields of view. The percentages of positive cells in different
zones were calculated for each case and then for the dif-
ferent groups.
Statistical analysis
Statistical analysis was performed using the SPSS 18.0
package. Differences in means were evaluated by one-way
analysis of variance (ANOVA) with Tukey’s post hoc test
for multiple comparisons. Student’s t test was applied to
evaluate the difference between two groups. A normality
test was applied first for continuous variables before any
further comparison analyses. Nonparametric methods
(e.g., Mann–Whitney U for pairwise comparisons) were
used when the data were not normally distributed. A P
value < 0.05 was considered to suggest a significant dif-
ference. The results of IHC and qRT-PCR are presented
in bar charts using GraphPad PRISM 6 (GraphPad, San
Diego, CA, USA).
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